Business Wire

Taro Pharmaceuticals Inc. Issues Voluntary Type I Recall of Taro-Zoledronic Acid Injection, 5 mg/100 mL, 100 mL Vial Due to Particulate Matter Over Specified Requirements

BRAMPTON, Ontario--(BUSINESS WIRE)--Taro Pharmaceuticals Inc. has initiated a voluntary Type 1 recall to the patient level on six (6) lots of Taro-Zoledronic Acid Injection, 5 mg/100 mL in 100 mL ...
NJBIZ

Novartis Gets Approval for Once-Yearly Osteoporosis Treatment

Novartis Pharmaceuticals Corp. in East Hanover, an affiliate of Novartis AG, says it has received approval from the Food and Drug Administration for zoledronic acid (Reclast) injection as a ...
Drug Store News

Avenacy intros generic Zometa

Zoledronic acid injection is indicated for the treatment of hypercalcemia of malignancy and for the treatment of multiple myeloma and bone metastases of solid tumors, in conjunction with standard ...
ascopubs.org

The effectiveness of therapy with octreotide LAR in combination treatment with zoledronic acid versus zoledronic acid alone.

Initial experience of radium-223 treatment for metastatic castrate resistant prostate cancer in community setting. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...
Reuters

Novartis AG: Reclast receives FDA approval as first and only once-yearly treatment for women with Postmenopausal Osteoporosis

The U.S. Justice Department on Friday announced criminal charges against a State Department employee accused of sharing sensitive government information with people he met online, according to a ...